Mineralys Therapeutics CEO Jon Congleton sells $291,441 in stock
Invest Market Updates
Mineralys Therapeutics CEO Jon Congleton sells $291,441 in stock
Mineralys Therapeutics CEO Jon Congleton sells $291,441 in stock Invest Market Updates
Continue Reading
Related market coverage
News
U.S. Economic Calendar – MarketWatch
The median forecasts in this calendar come from surveys of economists conducted by Dow Jones Newswires and The Wall Street Journal. All…
News
Coinbase Policy Chief Calls CLARITY Act a ‘Dramatic Advance’: Here’s What Comes Next in the Senate
Key Takeaways Coinbase’s Faryar Shirzad called the Clarity Act “a dramatic advance in consumer protection.” The Senate targets floor action the week…
News
New School economist: Trump Accounts will widen America’s wealth gaps
On July 4, the federal government launched what it described as one of the nation’s most ambitious asset-building initiatives for children in…